In a 53-year-old woman with intermittent activity‑induced facial and hand edema that resolves at rest, accompanied by several months of diffuse myalgias and fatigue, what is the most likely diagnosis and appropriate treatment plan?

Dermatomyositis with Polymyalgia-Like Features

The most likely diagnosis is dermatomyositis (or another inflammatory myopathy), and the patient requires urgent evaluation with creatine kinase (CK), inflammatory markers (ESR/CRP), autoantibody panel, and consideration of MRI or EMG to assess for myositis, followed by high-dose corticosteroids if confirmed.

Clinical Reasoning

This 53-year-old woman presents with a classic triad that strongly suggests an inflammatory myopathy:

• Activity-induced facial and hand edema that resolves at rest
• Diffuse myalgias lasting months
• Profound fatigue

The activity-induced edema affecting both hands and face is particularly characteristic of dermatomyositis, where generalized subcutaneous edema can occur as a rare but recognized manifestation 1. This pattern of intermittent edema distinguishes it from idiopathic edema (which is orthostatic and predominantly affects women, but lacks the myalgia component) 2.

Diagnostic Workup

Essential Laboratory Tests

1. Creatine kinase (CK) - Will be markedly elevated in myositis but normal in polymyalgia-like syndromes 3, 4
2. Inflammatory markers (ESR, CRP) - Typically highly elevated in inflammatory myopathies 3
3. Autoantibody panel including:
   • ANA, RF, anti-CCP
   • Myositis-specific antibodies
   • Anti-SSA, anti-SSB (for sicca symptoms if present)

Imaging and Specialized Testing

• MRI of affected muscles - Shows increased intensity and edema in inflammatory myositis 4
• EMG - Demonstrates muscle fibrillations indicative of myopathy 4
• Muscle biopsy - Can confirm diagnosis if imaging is equivocal 4

Critical Differential Considerations

Polymyalgia Rheumatica-Like Syndrome

Patients with this condition have:

• Severe proximal myalgia and fatigue
• Pain but not true weakness
• Normal CK levels (key differentiator) 3
• Highly elevated inflammatory markers
• No evidence of myopathy on MRI/EMG 3

True Inflammatory Myositis

Characterized by:

• Proximal muscle weakness (difficulty standing, lifting arms)
• Markedly elevated CK 4
• Myalgia in severe cases
• Can have fulminant necrotizing course with rhabdomyolysis 3, 4

Critical pitfall: The presence of generalized edema should not distract from evaluating for underlying inflammatory myopathy. In treatment-refractory cases with anasarca, malignancy screening with PET-CT is essential, as dermatomyositis can be paraneoplastic 1.

Treatment Algorithm

If CK is Markedly Elevated (Myositis Confirmed):

1. Immediate high-dose corticosteroids 4

   • Administer as bolus in severe cases
   • Monitor for cardiac involvement (myocarditis carries high mortality) 3

2. Consider additional immunosuppression:

   • Plasmapheresis for poor corticosteroid response 4
   • IVIG (particularly effective for treatment-refractory cases with anasarca) 1
   • Other immunosuppressants (azathioprine, mycophenolate mofetil) 1

3. Malignancy screening:

   • Initial comprehensive screen
   • PET-CT if treatment-refractory or high clinical suspicion 1

If CK is Normal (Polymyalgia-Like Syndrome):

1. Corticosteroids - NSAIDs alone are insufficient 3
2. Consider synthetic or biologic DMARDs if symptoms persist 3
3. Tailored physical activity interventions and psychoeducational support 5

Key Clinical Caveats

• Weakness vs. pain: True myositis causes weakness; polymyalgia-like syndrome causes pain without weakness 3
• Cardiac monitoring: Myositis with myocardial involvement has ominous prognosis and requires urgent treatment 3, 4
• Concomitant myasthenia gravis: Check for anti-acetylcholine receptor antibodies if bulbar symptoms develop 3
• Exercise-induced symptoms: While exercise-induced anaphylaxis exists 6, the chronic nature and myalgia make inflammatory myopathy far more likely

The combination of activity-induced edema, chronic myalgias, and fatigue in a middle-aged woman mandates urgent rheumatologic evaluation to distinguish between polymyalgia-like syndrome and true inflammatory myositis, as the latter requires aggressive immunosuppression to prevent potentially fatal complications.